Project Marvel

Ensuring the Safety and Efficacy of Clinical Trials

About The Client

Johnson & Johnson (J&J) is a globally renowned American multinational corporation specializing in the development of medical devices, pharmaceuticals, and consumer packaged goods. With a rich history of innovation and development, J&J has established itself as a leader in healthcare solutions.

My Role

Design Director overseeing (3) UX/UI Designers, (2) FED, (1) Editor, and (1) Business Analyst

Over $10 Million Engagement Revenue

Challenge + Opportunity

Before 2021, Perficient had successfully delivered several projects for J&J, albeit with a total revenue of less than $700K. The real opportunity emerged when Perficient’s Life Sciences experts presented a Clinical Data Review Platform (CDRP) Point of View (POV), showcasing their deep industry knowledge and expertise. This presentation led to an invitation to participate in an RFI for J&J’s initiative aimed at improving patient data flow within clinical trials.

The challenge was twofold: navigating the delays caused by the pandemic and developing a proof of concept (POC) that would address J&J’s critical needs. The primary concern for J&J was to find a user-friendly, future-proof solution for clinical data review and cleaning that would ensure the safety and efficacy of its clinical trials across the organization.

Solution Highlights

Under the creative direction of the project’s Creative Director, the solution, dubbed Project Marvel, was designed from the ground up, incorporating a comprehensive design system to ensure consistency and usability across all interfaces. This custom-built clinical data review and cleaning environment was developed to provide an accurate, real-time view of clinical studies, with a focus on user experience and scalability.

Key Benefits

The design and implementation of Project Marvel, under visionary leadership, have culminated in a pivotal transformation for Johnson & Johnson, offering multifaceted benefits:

  • Enhanced Monitoring and Usability: Project Marvel’s user-centric design and robust UI facilitate real-time monitoring of clinical trial safety and efficacy, significantly improving adoption and usability across the organization.
  • Unified Collaboration and Decision-making: A cohesive design system and integrated platform foster improved collaboration and decision-making across diverse teams, enhancing operational efficiency and strategic agility.
  • Scalability and Future-proofing: The solution’s scalable architecture and use of cutting-edge technologies like AI and machine learning ensure it is equipped to meet future challenges and technological evolutions, securing long-term value and adaptability.
  • Revenue Growth and Expansion Potential: With a service revenue boost to approximately $10M and prospects for future expansions, Project Marvel not only promises enhanced clinical trial management for J&J but also reinforces Perficient’s standing as an innovator in healthcare solutions, reflecting the strategic acumen and creative insight of the project’s leadership. This 30-week engagement marks a significant stride towards setting new standards in clinical trial oversight and management.